Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

ClinicalTrials.gov ID: NCT01487109

Public ClinicalTrials.gov record NCT01487109. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to evaluate the safety and efficacy of treatment with CTP-499 for 24 weeks in patients with chronic kidney disease, Type 2 diabetic nephropathy and who are currently receiving treatment with an angiotensin converting enzyme inhibitor (ACEI) and/or angiotensin II receptor blocker (ARB).

Study identification

NCT ID
NCT01487109
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Concert Pharmaceuticals
Industry
Enrollment
170 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2012 (Type not available)
Primary completion
Jan 2015 (Actual)
Completion
Jan 2015 (Actual)
Last update posted
Aug 16, 2021

2012 – 2015

United States locations

U.S. sites
49
U.S. states
20
U.S. cities
41
Facility City State ZIP Site status
Agave Clinical Research Tempe Arizona 85282 —
Harrisburg Family Medical Center Harrisburg Arkansas 72432 —
Arkansas Primary Care Clinic Little Rock Arkansas 72204 —
Providence Clinical Research Burbank California 91505 —
California Institute of Renal Research Chula Vista California 91910 —
SC Clinical Research Garden Grove California 92844 —
Premiere Clinical Research Lakewood California 90712 —
Long Beach Center for Clinical Research Long Beach California 90806 —
Premiere Clinical Research Long Beach California 90807 —
UCLA Kidney Transplant Research Los Angeles California 90024 —
David Geffen School of Medicine Division of Nephrology Los Angeles California 90095 —
Desert Oasis Healthcare Medical Group Palm Springs California 92262 —
Apex Research of Riverside Riverside California 92505 —
River City Clinical Research Sacramento California 95816 —
California Institute of Renal Research San Diego California 92123 —
Samsun Clinic Santa Barbara California 93110 —
Orange County Research Center Tustin California 92780 —
Infosphere Clinical Research West Hills California 91307 —
Creekside Endocrine Associates Denver Colorado 80209 —
Palm Spring Research Institute Hialeah Florida 33012 —
San Marcus Research Clinic, Inc. Miami Florida 33015 —
Advanced Pharma CR Miami Florida 33136 —
Ormond Medical Arts Pharmaceutical Research Ormond Beach Florida 32174 —
Clincal Research of Central Florida Winter Haven Florida 33880 —
River Birch Research Alliance Blue Ridge Georgia 30513 —
Apex Medical Research Chicago Illinois 60616 —
University of Chicago Medical Center Chicago Illinois 60637 —
American Health Network of IN Avon Indiana 46123 —
American Healthcare Network of Indiana Greenfield Indiana 46140 —
Medstar Health Research Institute Hyattsville Maryland 20782 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Harvard Medical School Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Apex Medical Research MI Flint Michigan 48504 —
Clinical Research Consultants (MO) Kansas City Missouri 64111 —
The Rogosin Institute New York New York 10021 —
Clinical Research Development Associates (NY) Rosedale New York 11422 —
University of North Carolina School of Medicine Chapel Hill North Carolina 27599 —
Clinical Research Limited Canton Ohio 44718 —
Lynn Institute of Norman Norman Oklahoma 73069 —
C.S.R.A. Renal Services Aiken South Carolina 29801 —
Pharmacorp Clinical Trials Charleston South Carolina 29412 —
Mountain View Clinical Research Greer South Carolina 29651 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Millenium Clinical Research Houston Texas 77054 —
Research Across America Houston Texas 77054 —
Renal Associates San Antonio Texas 78215 —
Panacea Clinical Research San Antonio Texas 78228 —
Cetero San Antonio Texas 78229 —
Multicare Research Institute (WA) Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01487109, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 16, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01487109 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →